THE RED PILL, EXTRA STRENGTH capsules, 800 mg, packaged in 10-count blisters packaged in a carton, ASIN B0847BSQQ5, Barcode X002G5GMJ1.
Published February 23, 2022 · Recall initiated: February 8, 2022
Summary
FDA records drug Class I recall D-0630-2022, published February 23, 2022 and initiated February 8, 2022. Recalling firm: Your Favorite Shop; Status: Terminated; Reported quantity: 12,500 cartons; Lot: Lot # 26436989, Exp. date 10/30/2023. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Your Favorite Shop
- Distributor
- Product was distributed nationwide in the USA via the internet through Amazon Marketplace.
- Lot
- Lot # 26436989, Exp. date 10/30/2023
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAChlorthalidone Tablets USP 25 mg, Rx Only, 100 Tablets, Sun Pharma, Mfg. by: Fontida Bio Pharm Inc., 1100February 23, 2022
- FDA365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONALFebruary 23, 2022
- FDAPyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc.February 23, 2022
- FDAHYDROmorphone HCl PF 10 mg/50 mL (0.2mg/mL) in NaCl, 50 mL in 50 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
- FDAAlprazolam Tablets, USP 2.0 mg, packaged in a) 100-count bottles (NDC 67253-903-10), b) 500-count bottles (NDCFebruary 23, 2022
- FDAMorphine Sulfate PF 25 mg/25mL (1 mg/mL) in NaCl, 25 mL in 30 mL Single Dose Syringe, Rx only, STAQ Pharma,February 23, 2022
Questions about this recall
Was THE RED PILL, EXTRA STRENGTH capsules, 800 mg, packaged in 10-count blisters packaged in a carton, ASIN B0847BSQQ5, Barcode X002G5GMJ1. recalled?
Yes. FDA published recall D-0630-2022 on February 23, 2022. Reported hazard: Marketed Without An Approved NDA/ANDA: Product was found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release